← Back to guidelines
Cardiology7 papers

Systemic aspergillosis

Last edited: 4/22/2026

Overview

Systemic aspergillosis involves hematogenous dissemination of Aspergillus fungi, primarily affecting immunocompromised individuals, leading to multi-organ involvement including rare complications such as aortic thrombi and myocardial infarction 12.

Diagnosis

  • Clinical Presentation: Signs of sepsis, respiratory distress, and neurological symptoms (e.g., encephalitis) 1.
  • Imaging: Transesophageal echocardiography for detection of large vessel thrombi 1.
  • Cardiac Involvement: Suspect fungal etiology in myocardial infarction cases with coronary artery occlusion, especially in immunosuppressed patients 2.
  • Laboratory Tests: Blood cultures, galactomannan antigen testing, and imaging studies to identify organ involvement 12.
  • Management

  • First-Line Treatment: Amphotericin B (0.6 mg/kg/day) as initial antifungal therapy 2.
  • Adjunctive Therapies: Surgical intervention may be necessary for localized complications (e.g., thrombi) 1.
  • Supportive Care: Management of septic shock, respiratory support, and neurological care as indicated 1.
  • Special Populations

  • Immunocompromised Patients: Higher risk for systemic involvement and complications like myocardial infarction 2.
  • No Specific Guidance: Abstracts do not provide detailed guidance for pregnancy, pediatrics, or elderly populations 12.
  • Key Recommendations

  • Utilize transesophageal echocardiography for early detection of large vessel involvement in critically ill patients suspected of systemic aspergillosis (Evidence: Moderate) 1.
  • Consider systemic aspergillosis as a potential cause of myocardial infarction in immunosuppressed patients presenting with chest symptoms (Evidence: Weak) 2.
  • Initiate treatment with amphotericin B (0.6 mg/kg/day) for systemic aspergillosis in immunocompromised individuals (Evidence: Moderate) 2.
  • References

    1 Grothues F, Welte T, Grote HJ, Roessner A, Klein HU. Floating aortic thrombus in systemic aspergillosis and detection by transesophageal echocardiography. Critical care medicine 2002. link 2 Andersson BS, Luna MA, McCredie KB. Systemic aspergillosis as cause of myocardial infarction. Cancer 1986. link58:9<2146::aid-cncr2820580931>3.0.co;2-4)

    Original source

    1. [1]
      Floating aortic thrombus in systemic aspergillosis and detection by transesophageal echocardiography.Grothues F, Welte T, Grote HJ, Roessner A, Klein HU Critical care medicine (2002)
    2. [2]
      Systemic aspergillosis as cause of myocardial infarction.Andersson BS, Luna MA, McCredie KB Cancer (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG